PhoenixBio: Announcements of individual stocks regarding the recognition of non-operating income (foreign exchange gains)
PhoenixBio: Short message of first quarter financial results for the fiscal year of March 2025 [Japan Standard] (Consolidated)
PhoenixBio: Announcements of individual stocks regarding the passing of the chairman of the board of directors and changes in company executives.
PhoenixBio: Announcements of individual stocks regarding the completion of payment for new shares as restricted stock compensation.
PhoenixBio: Interim report
PhoenixBio: Corporate Governance Report 07/01/2024
PhoenixBio: Extraordinary Report
PhoenixBio: Internal control report - The 23rd term (April 1, 2023 - March 31, 2024)
PhoenixBio: Confirmatory letter.
PhoenixBio: Financial Report - Term 23 (2023/04/01 - 2024/03/31)
PhoenixBio: Announcement of changes in the representative director.
PhoenixBio: Announcements of individual stocks regarding the issuance of new stocks with transfer restrictions as stock compensation
PhoenixBio: Explanatory material about business plans and growth potential.
PhoenixBio: Regarding matters related to dominant shareholders.
PhoenixBio: Notice of Convening Regular Shareholders' Meeting for the Year 2024.
PHOENIXBIO: Notice regarding financial results of unlisted parent companies, etc.
PHOENIXBIO: Summary of financial results for the fiscal year ending March 31, 2024 [Japanese GAAP] (consolidated)
PhoenixBio: About the conclusion of a business alliance agreement with Ecocell Co., Ltd.
Phoenix Bio: Confirmation Letter
Phoenix Bio: Quarterly Report - 23rd Quarter (2023/10/01 to 2023/12/31)
No Data
No Data